Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiji Yano

Showing results (61-70 of 286) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient miceQi Li, Seiji Yano, Hirokazu Ogino, et al.
In Vivo (Athens, Greece)|January 6, 2021
Sarcopenia may Influence the Prognosis in Advanced Thyroid Cancer Patients Treated With Molecular Targeted TherapyAkihiro Nishiyama, Yukiko Staub, Yukio Suga, et al.
Journal of Pharmaceutical Health Care and Sciences|July 12, 2016
Elevated prothrombin time/international normalized ratio associated with concurrent administration of regorafenib and warfarin in a patient with advanced colorectal cancerHironori Kitade, Azusa Hiromasa-Yamasaki, Kengo Hokkoku, et al.
Cancer Research|July 5, 2002
Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude miceHisatsugu Goto, Seiji Yano, Helong Zhang, et al.
Oncology Letters|September 25, 2025
Combination of immune checkpoint inhibitors and radiotherapy for bone metastases induces an abscopal effect and improves outcomes in non-small cell lung cancerYohei Asano, Katsuhiro Hayashi, Shinji Miwa, et al.
Scientific Reports|October 8, 2020
Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasionKatsuya Sakai, Takumi Nishiuchi, Shoichiro Tange, et al.
Oncology Research|June 21, 2006
ZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, inhibits growth of experimental lung metastasis and production of malignant pleural effusions in a non-small cell lung cancer modelYuka Matsumori, Seiji Yano, Hisatsugu Goto, et al.
International Journal of Cancer|January 8, 2003
A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude miceAkihiko Yamamoto, Seiji Yano, Minoru Shiraga, et al.
Anti-Cancer Drugs|April 8, 2003
Immunohistochemical expression of receptor-tyrosine kinase c-kit protein in invasive ductal carcinoma of the pancreasYoshinori Nio, Hiroshi Omori, Tomoko Toga, et al.
Cancer Science|June 26, 2003
A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 ("Iressa")Seiji Yano, Takanori Kanematsu, Toyokazu Miki, et al.
Pageof 29

Showing results (61-70 of 286) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient miceQi Li, Seiji Yano, Hirokazu Ogino, et al.
In Vivo (Athens, Greece)|January 6, 2021
Sarcopenia may Influence the Prognosis in Advanced Thyroid Cancer Patients Treated With Molecular Targeted TherapyAkihiro Nishiyama, Yukiko Staub, Yukio Suga, et al.
Journal of Pharmaceutical Health Care and Sciences|July 12, 2016
Elevated prothrombin time/international normalized ratio associated with concurrent administration of regorafenib and warfarin in a patient with advanced colorectal cancerHironori Kitade, Azusa Hiromasa-Yamasaki, Kengo Hokkoku, et al.
Cancer Research|July 5, 2002
Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude miceHisatsugu Goto, Seiji Yano, Helong Zhang, et al.
Oncology Letters|September 25, 2025
Combination of immune checkpoint inhibitors and radiotherapy for bone metastases induces an abscopal effect and improves outcomes in non-small cell lung cancerYohei Asano, Katsuhiro Hayashi, Shinji Miwa, et al.
Scientific Reports|October 8, 2020
Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasionKatsuya Sakai, Takumi Nishiuchi, Shoichiro Tange, et al.
Oncology Research|June 21, 2006
ZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, inhibits growth of experimental lung metastasis and production of malignant pleural effusions in a non-small cell lung cancer modelYuka Matsumori, Seiji Yano, Hisatsugu Goto, et al.
International Journal of Cancer|January 8, 2003
A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude miceAkihiko Yamamoto, Seiji Yano, Minoru Shiraga, et al.
Anti-Cancer Drugs|April 8, 2003
Immunohistochemical expression of receptor-tyrosine kinase c-kit protein in invasive ductal carcinoma of the pancreasYoshinori Nio, Hiroshi Omori, Tomoko Toga, et al.
Cancer Science|June 26, 2003
A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 ("Iressa")Seiji Yano, Takanori Kanematsu, Toyokazu Miki, et al.
Pageof 29